Pfizer Inc (NYSE:PFE)
| 34.51 Delayed Data As of Jul 06 |  0.00 / 0.00%Today’s Change | 27.88 Today|||52-Week Range 44.11 | -11.92% Year-to-Date |
Latest PFE News | Press Releases
| Will an Ad Boycott End Facebook’s 500% Rally Over the Past 8 Years? Jul 06 / MotleyFool.com - Paid Partner Content | Stocks rise after jobs report Jul 02 / CNN.com - Paid Partner Content |
| No Joke: Tesla Could Be Helping Make a Coronavirus Vaccine Jul 05 / MotleyFool.com - Paid Partner Content | Why Pfizer Stock Rose Today Jul 01 / MotleyFool.com - Paid Partner Content |
| Inovio Stock: Buy, Sell, or Hold? Jul 04 / MotleyFool.com - Paid Partner Content | Why Alteryx Stock Climbed Today Jul 01 / MotleyFool.com - Paid Partner Content |
| These 3 Things Could Send Novavax's Stock Soaring to New Heights Jul 02 / MotleyFool.com - Paid Partner Content | Why COVID-19 Vaccine Developer Dynavax Is Down 6.5% Today Jul 01 / MotleyFool.com - Paid Partner Content |
| 2 Healthcare Stocks That Could Soar in 2020 Jul 02 / MotleyFool.com - Paid Partner Content | Pfizer and BioNTech Post Positive Trial Data for Their COVID-19 Vaccine Jul 01 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 34.51 |
| Today’s open | 34.99 |
| Day’s range | 34.38 - 34.99 |
| Volume | 25,759,949 |
| Average volume (3 months) | 32,888,335 |
| Market cap | $191.7B |
Data as of 4:07pm ET, 07/06/2020
Growth & Valuation
| Earnings growth (last year) | +53.85% |
| Earnings growth (this year) | -10.56% |
| Earnings growth (next 5 years) | +6.04% |
| Revenue growth (last year) | -3.54% |
| P/E ratio | 12.3 |
| Price/Sales | 4.30 |
| Price/Book | 3.03 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | +0.79 | +1.00% |
| NVSNovartis | +0.85 | +0.97% |
| ABBVAbbVie | +0.14 | +0.14% |
| LLYEli Lilly and Co | +3.07 | +1.87% |
Data as of 4:14pm ET, 07/06/2020
Financials
| Next reporting date | July 28, 2020 |
| EPS forecast (this quarter) | $0.68 |
| Annual revenue (last year) | $51.8B |
| Annual profit (last year) | $16.3B |
| Net profit margin | 31.44% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
